This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilyinskii, P. O.
Right arrow Articles by Exley, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilyinskii, P. O.
Right arrow Articles by Exley, M. A.

 Previous Article  |  Next Article 

Journal of Virology, July 2006, p. 7146-7158, Vol. 80, No. 14
0022-538X/06/$08.00+0     doi:10.1128/JVI.02745-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

CD1d Mediates T-Cell-Dependent Resistance to Secondary Infection with Encephalomyocarditis Virus (EMCV) In Vitro and Immune Response to EMCV Infection In Vivo

Petr O. Ilyinskii ,{dagger} Ruojie Wang, Steven P. Balk, and Mark A. Exley*

Cancer Biology Program, Hematology/Oncology Division, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215

Received 30 December 2005/ Accepted 4 May 2006

The innate and adaptive immune responses have evolved distinct strategies for controlling different viral pathogens. Encephalomyocarditis virus (EMCV) is a picornavirus that can cause paralysis, diabetes, and myocarditis within days of infection. The optimal innate immune response against EMCV in vivo requires CD1d. Interaction of antigen-presenting cell CD1d with distinct natural killer T-cell ("NKT") populations can induce rapid gamma interferon (IFN-{gamma}) production and NK-cell activation. The T-cell response of CD1d-deficient mice (lacking all NKT cells) against acute EMCV infection was further studied in vitro and in vivo. EMCV persisted at higher levels in CD1d-knockout (KO) splenocyte cultures infected in vitro. Furthermore, optimal resistance to repeat cycles of EMCV infection in vitro was also shown to depend on CD1d. However, this was not reflected in the relative levels of NK-cell activation but rather by the responses of both CD4+ and CD8+ T-cell populations. Repeated EMCV infection in vitro induced less IFN-{gamma} and alpha interferon (IFN-{alpha}) from CD1d-deficient splenocytes than with the wild type. Furthermore, the level of EMCV replication in wild-type splenocytes was markedly and specifically increased by addition of blocking anti-CD1d antibody. Depletion experiments demonstrated that dendritic cells contributed less than the combination of NK and NKT cells to anti-EMCV responses and that none of these cell types was the main source of IFN-{alpha}. Finally, EMCV infection in vivo produced higher levels of viremia in CD1d-KO mice than in wild-type animals, coupled with significantly less lymphocyte activation and IFN-{alpha} production. These results point to the existence of a previously unrecognized mechanism of rapid CD1d-dependent stimulation of the antiviral adaptive cellular immune response.

* Corresponding author. Mailing address: Hematology/Oncology Division, Beth Israel Deaconess Medical Center, NRB 1030L, 330 Brookline Avenue, Boston, MA 02215. Phone: (617) 667-0982. Fax: (617) 667-0890. E-mail: mexley{at}bidmc.harvard.edu.

{dagger} Present address: Cure Lab, Inc., 216 Bolivar St., Canton, MA 02021.

Journal of Virology, July 2006, p. 7146-7158, Vol. 80, No. 14
0022-538X/06/$08.00+0     doi:10.1128/JVI.02745-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Renukaradhya, G. J., Khan, M. A., Shaji, D., Brutkiewicz, R. R. (2008). Vesicular Stomatitis Virus Matrix Protein Impairs CD1d-Mediated Antigen Presentation through Activation of the p38 MAPK Pathway. J. Virol. 82: 12535-12542 [Abstract] [Full Text]  
  • Martinez, J., Huang, X., Yang, Y. (2008). Direct Action of Type I IFN on NK Cells Is Required for Their Activation in Response to Vaccinia Viral Infection In Vivo. J. Immunol. 180: 1592-1597 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»